Continued:
- Letter (December 1): ACLA Letter on COVID Vaccine Distribution
- Statement (November 12): Update on PCR Testing Capacity
- Blog (November 10): Serologic Testing Provides a Surveillance Strategy for the Fight Against COVID-19
- Blog (November 9): Protecting Our Nation Through Robust Access to COVID-19 Testing
- Statement (November 8): ACLA Statement on Key Priorities for the Incoming Biden Administration, New Congress
- Resource (October 30): Value of Multiplex Testing in Response to COVID-19, Flu Season
- Statement (October 15): ACLA Statement on CMS Reimbursement Policy
- LinkedIn Article (October 15): After 50 million COVID-19 Tests Performed, Reflections on What We’ve Learned
- Statement (October 7): ACLA Statement on FDA Announcement Regarding EUA Reviews
- Blog (September 3): Maintaining and Expanding Access to COVID-19 Testing: The Critical Need for Sustainable Reimbursement
- Statement (August 21): ACLA Statement on Recent HHS Announcement Regarding Regulation of Laboratory Developed Tests
- Resource (July 31): Access To COVID-19 Testing Fact Sheet
- Blog (July 30): With the help of clinical labs, “The Fight Is In Us” aims to boost convalescent plasma donations nationwide
- Statement (July 27): ACLA Statement on Senate Republicans’ Coronavirus Relief Package
- Resource (July 22): COVID-19 Information and Resources for Providers
- Statement (July 22): 49 Organizations Ask Congress To Dedicate Federal Funding for COVID-19 Testing
- Statement (July 14): ACLA Update on PCR Testing Capacity for COVID-19
- Letter (June 26): ACLA Letter to Chairman Lamar Alexander on Pandemic Response White Paper
- Statement (June 27): ACLA Update on Testing Capacity
- Letter: (June 23): ACLA Joins Key Stakeholders Calling For Extension of Public Health Emergency Declaration
- Letter (June 23): ACLA Letter to HHS on Data Reporting
- Statement (June 23): ACLA Statement on New Tri-Agency Guidance
- Letter (June 15): ACLA Letter to CDC on Antibody Guidance
- Statement (June 8): Lawmakers Call on HHS to Designate Resources for Clinical Labs
- Statement (June 4): ACLA Statement on New Data Reporting Guidance
- Resource (May 29): COVID-19 Frequently Asked Questions
- Statement (May 19): ACLA Statement on Medicare Reimbursement Rate For Serologic Testing
- Statement (May 12): ACLA Statement on HEROES Act
- Statement (May 11): ACLA Statement on Expanding Access to Testing
- Statement (May 6): ACLA Statement on Support Necessary For Laboratories
- Statement (May 4): ACLA Statement on FDA’s Revised Policy For Serologic Tests
- Letter (April 29): ACLA Letter to HHS on PHSSEF Direct COVID-19 Test Funding
- Statement (April 27): ACLA Statement on White House Meeting
- Statement (April 21): ACLA Statement on the Paycheck Protection Program and Health Care Enhancement Act
- Press Release (April 20): Clinical Labs Support Congressional Funding To Ensure Robust Testing Infrastructure
- Press Release (April 20): Dave King joins ACLA as Special Advisor
- Press Release (April 19): As Nation Recognizes Laboratory Professionals Week, ACLA Highlights Extraordinary Efforts of “The Laboratory People”
- ACLA Serologic Testing White Paper & Executive Summary (April 16): White Paper & Executive Summary
- Statement (April 15): CMS Takes Decisive Action to Support Laboratories Responding to COVID-19 Pandemic
- WSJ Letter to the Editor (April 3): Where Are Clinical Labs in the Coronavirus Plan?
- Letter (April 2): Letter to CDC on Prioritization
- Letter (April 2): Letter to HHS on COVID-19 Provider Fund
- Statement (March 29): ACLA President Julie Khani Outlines Key Challenges Facing Testing Capacity
- Statement (March 25): ACLA Statement on CARES Act
- Statement (March 23): With Congress on its third financial relief package, policymakers fail to recognize critical role of labs
- What They Are Saying (March 23): National Demand for COVID-19 Testing Requires Congress to Act, Approve Funding & Reimbursement for Testing Capacity
- Statement (March 22): ACLA Statement on Senate COVID-19 Response Effort
- LinkedIn Post (March 22): As Nation Faces Testing Shortage, Congress Needs to Have Our Back
- Statement (March 21): Without Sustainable Funding, There’s Simply No Way To Have Sustainable Testing
- Statement (March 20): ACLA Statement on Stimulus Bill
- Press Release (March 19): Facing Unprecedented Demand for Testing, Clinical Labs Ask Congress for Surge Capacity Fund
- Letter (March 18): ACLA Letter to Congressional Leadership on COVID-19
- Statement (March 17): On Recent FDA Actions To Expand COVID-19 Testing
- Press Release (March 13): Commercial Labs Step Up Capacity, Collaborate With Public Health Partners To Respond To National Emergency
- Press Release (March 5): Commercial Labs Announce Plans to Provide COVID-19 Testing
- Statement (March 4): ACLA Statement on COVID-19 Testing
- Press Release (February 29): FDA expands coronavirus testing capacity with support of commercial labs
- Press Release (February 28): Update on COVID-19 Outbreak
